Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-09-30Integrated Care in Patients With a Psychotic Disorder Fulfilling Definition of Severe Mental Illness (ACCESS-II Study)
-
CLINICAL_TRIALS study record update · 2021-09-29Effects of Oxytocin on Negative Symptoms and Social Cognition in Schizophrenia and Its Behavioral Mechanisms
-
CLINICAL_TRIALS study record update · 2021-09-28Cognitive Remediation of the Ability to Infer Intention of Others in Schizophrenic Patients - A Controlled, Randomized Trial (Phase IIb)
-
CLINICAL_TRIALS study record update · 2021-09-28Adapting Critical Time Intervention to Support Inpatient Medical Care Transition
-
CLINICAL_TRIALS study record update · 2021-09-27Modulation of rTMS on Hippocampal Neurogenesis and Functional Network in Early Schizophrenia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-09-27The Effect of Repetitive Transcranial Magnetic Stimulation in Schizophrenia--A Randomized , Double-blind fMRI Study
-
CLINICAL_TRIALS study record update · 2021-09-22A 4-Week, Randomized, Double-blind, Parallel-group, Placebo-controlled, Flexibly-dosed, Multicenter Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adult Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-09-22A 17-Week, Phase 2, Multicenter, Randomized, Double-Blind Study of Treatment With LY2140023 Combined With Standard of Care (SOC) Compared to Placebo With SOC in the Treatment of Patients With Prominent Negative Symptoms of Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-09-20Involuntary Memories Investigation in Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-09-17Multi-component Intervention for Diabetes in Adults With Serious Mental Illness (MIDAS)
-
CLINICAL_TRIALS study record update · 2021-09-16Assessment of Efficacy of a Psychological Therapy in Inpatients With a Schizophrenic Psychosis
-
CLINICAL_TRIALS study record update · 2021-09-16A Phase 3, Short-Term, Multicenter, Placebo-Controlled, Randomized Withdrawal Study of LY2140023 Monohydrate in Patients With DSM-IV-TR Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-09-14ClinicalTrials.gov study NCT02640911
-
CLINICAL_TRIALS study record update · 2021-09-14A Multicenter, Double-Blind, Placebo-Controlled Study of 3 Doses of LY2140023 in Patients With DSM-IV-TR Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-09-14Safety and Tolerability of Multiple Ascending Doses of LY2140023 in Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-09-08A Phase 2, Randomized, Multicenter, Safety, Tolerability, and Dose-Ranging Study of Samidorphan, a Component of ALKS 3831, in Adults With Schizophrenia Treated With Olanzapine
-
CLINICAL_TRIALS study record update · 2021-09-05A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
-
CLINICAL_TRIALS study record update · 2021-09-05Development of a Mobile Heath Augmented Brief Suicide Prevention Intervention for People With SMI Accessing Community Care
-
CLINICAL_TRIALS study record update · 2021-08-31Understanding the Neurobiological Effects of Oxytocin on Social Trust Deficits in Schizophrenia: A Multimodal Imaging - Genetics Study
-
CLINICAL_TRIALS study record update · 2021-08-27Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
-
CLINICAL_TRIALS study record update · 2021-08-26Neuroimaging of Tryptophan Challenge in People With Schizophrenia and Healthy Controls
-
CLINICAL_TRIALS study record update · 2021-08-24A Research on High-Definition Transcranial Direct Current Stimulation as a Treatment of Negative Symptoms in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-08-20A Randomized, Double-Blind Comparison of LY2140023, Olanzapine, and Placebo in the Treatment of Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-08-20An Ascending Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NSA-789 Administered Orally to Subjects With Schizophrenia or Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2021-08-20A Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Effects of Single Oral Doses of NSA-789 on Auditory P50 Suppression in Nonsmoking Patients With Stabilized Schizophrenia